- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Equine CEA antibody and antigen (recombinant protein)
Diagnostic anti-Equine CEA antibodies pairs and antigen for animal health (animal Equine/Horse breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-EQU-CEA-Ag01 | Equine CEA | $3090.00 |
| GMP-EQU-CEA-Ab01 | Anti-Equine CEA mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CEA-Ab02 | Anti-Equine CEA mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CEA-Ab03 | Anti-Equine CEA human monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-CEA-Ab04 | Anti-Equine CEA human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-EQU-CEA-Ag01 |
| Product Name | Equine CEA |
| Target/Biomarker | Equine CEA |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Equine CEA antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
| Tag | His | Reconized/Reactive Specics | Equine CEA |
| Product description | Recombinant Equine CEA protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-CEA-Ab01,GMP-EQU-CEA-Ab02 |
| Target/Biomarker | Equine CEA |
| Product Name | Anti-Equine CEA mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Equine CEA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies in Equine CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
| Product description | Anti-Equine CEA mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-CEA-Ab03,GMP-EQU-CEA-Ab04 |
| Target/Biomarker | Equine CEA |
| Product Name | Anti-Equine CEA human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Equine CEA antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CEA antibodies in Equine CEA level test of animal Equine/Horse with breast cancer, lung cancer, breast cancer, liver cancer, pancreatic cancer, stomach cancer, ovarian cancer. |
| Product description | Anti-Equine CEA mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Carcinoembryonic Antigen (CEA) in horses (equines) is a glycoprotein biomarker with important implications in various physiological and pathological processes. Structurally, CEA belongs to the immunoglobulin superfamily and features multiple immunoglobulin-like domains, enabling its role in cell adhesion processes and tissue development. While CEA is actively produced during fetal development, its presence in healthy adult horses is typically limited to very low levels.
During fetal development, CEA is involved in cell adhesion, promoting the formation and integrity of various tissues. Its function is primarily to mediate interactions between cells, contributing to the organization and stability of tissues during embryonic growth.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
